Literature DB >> 32486083

The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets.

Etienne Ho Kit Mok1, Terence Kin Wah Lee1,2.   

Abstract

Cholesterol plays an important role in cellular homeostasis by maintaining the rigidity of cell membranes, providing a medium for signaling transduction, and being converted into other vital macromolecules, such as sterol hormones and bile acids. Epidemiological studies have shown the correlation between cholesterol content and cancer incidence worldwide. Accumulating evidence has shown the emerging roles of the dysregulation of cholesterol metabolism in cancer development. More specifically, recent reports have shown the distinct role of cholesterol in the suppression of immune cells, regulation of cell survival, and modulation of cancer stem cells in cancer. Here, we provide a comprehensive review of the epidemiological analysis, functional roles, and mechanistic action of cholesterol homeostasis in regard to its contribution to cancer development. Based on the existing data, cholesterol homeostasis is identified to be a new key player in cancer pathogenesis. Lastly, we also discuss the therapeutic implications of natural compounds and cholesterol-lowering drugs in cancer prevention and treatment. In conclusion, intervention in cholesterol metabolism may offer a new therapeutic avenue for cancer treatment.

Entities:  

Keywords:  cancer; cancer stem cells; cholesterol esters; cholesterol homeostasis; cholesterol-lowering drugs; immunotherapy; lipoproteins; oxysterols; statins

Year:  2020        PMID: 32486083     DOI: 10.3390/cancers12061410

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  10 in total

1.  Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer.

Authors:  Seungyoon Nam; Yongmin Lee
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

Review 2.  The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.

Authors:  Borja Guerra; Carlota Recio; Haidée Aranda-Tavío; Miguel Guerra-Rodríguez; José M García-Castellano; Leandro Fernández-Pérez
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 3.  Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?

Authors:  Rosa Vona; Elisabetta Iessi; Paola Matarrese
Journal:  Front Cell Dev Biol       Date:  2021-03-19

4.  Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort.

Authors:  Jun-Jun Yeh; Jung-Nien Lai; Cheng-Li Lin; Chung-Y Hsu; Chia-Hung Kao
Journal:  BMJ Open       Date:  2021-10-11       Impact factor: 3.006

5.  Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.

Authors:  Masato Karayama; Yusuke Inoue; Hideki Yasui; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda
Journal:  BMC Pulm Med       Date:  2021-12-11       Impact factor: 3.317

Review 6.  Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity.

Authors:  Mabel Catalán; Ivonne Olmedo; Jennifer Faúndez; José A Jara
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

7.  Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis.

Authors:  Yuanbin He; Xu Cui; Yu Lin; Yunjin Wang; Dianming Wu; Yifan Fang
Journal:  Biomed Res Int       Date:  2021-01-28       Impact factor: 3.411

8.  Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.

Authors:  Alessio Cortellini; Marco Tucci; Vincenzo Adamo; Luigia Stefania Stucci; Alessandro Russo; Enrica Teresa Tanda; Francesco Spagnolo; Francesca Rastelli; Renato Bisonni; Daniele Santini; Marco Russano; Cecilia Anesi; Raffaele Giusti; Marco Filetti; Paolo Marchetti; Andrea Botticelli; Alain Gelibter; Mario Alberto Occhipinti; Riccardo Marconcini; Maria Giuseppa Vitale; Linda Nicolardi; Rita Chiari; Claudia Bareggi; Olga Nigro; Alessandro Tuzi; Michele De Tursi; Nicola Petragnani; Laura Pala; Sergio Bracarda; Serena Macrini; Alessandro Inno; Federica Zoratto; Enzo Veltri; Barbara Di Cocco; Domenico Mallardo; Maria Grazia Vitale; David James Pinato; Giampiero Porzio; Corrado Ficorella; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

Review 9.  Statins: a repurposed drug to fight cancer.

Authors:  Wen Jiang; Jin-Wei Hu; Xu-Ran He; Wei-Lin Jin; Xin-Yang He
Journal:  J Exp Clin Cancer Res       Date:  2021-07-24

10.  Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.

Authors:  Masato Karayama; Naoki Inui; Yusuke Inoue; Katsuhiro Yoshimura; Kazutaka Mori; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Kazuhiro Asada; Tomohiro Uto; Masato Fujii; Takashi Matsui; Shun Matsuura; Dai Hashimoto; Mikio Toyoshima; Hideki Kusagaya; Hiroyuki Matsuda; Nao Inami; Yusuke Kaida; Mitsuru Niwa; Yasuhiro Ito; Takafumi Suda
Journal:  Cancer Immunol Immunother       Date:  2021-06-05       Impact factor: 6.968

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.